natgillin/translations-raw huggingface dataset:
Because of the potential for serious adverse reactions in nursing infants a decision should be made on whether to discontinue breast-feeding or discontinue Betaferon therapy.
Zbog mogućih ozbiljnih nuspojava u dojenčadi, potrebno je odlučiti da li prekinuti dojenje ili prekinuti liječenje lijekom Betaferon.
Because of the potential for serious adverse reactions in nursing infants a decision should be made whether to discontinue breast- feeding or Extavia therapy.
Zbog mogućnosti nastupa ozbiljnih nuspojava u djece koja doje, treba odlučiti treba li prekinuti dojenje ili liječenje Extavijom.
Because of the potential for serious adverse reactions in nursing infants from TRISENOX, breastfeeding must be discontinued prior to and throughout administration.
Prije i tijekom primjene TRISENOXA mora se prekinuti dojenje zbog mogućnosti nastanka ozbiljnih nuspojava kod dojenčadi.
Because of the potential for serious adverse reactions in nursing infants, a decision should be made either to discontinue breast-feeding or AVONEX therapy.
Zbog mogućnosti razvoja ozbiljnih nuspojava u dojenčadi, treba prekinuti ili dojenje ili terapiju AVONEXOM.
Because of the potential for serious adverse reactions of ONIVYDE in breast-feeding infants, ONIVYDE is contraindicated during breast-feeding (see section 4.3).
Zbog potencijalnih ozbiljnih nuspojava lijeka ONIVYDE kod dojenčadi na majčinom mlijeku, lijek ONIVYDE je kontraindiciran tijekom dojenja (vidjeti dio 4.3).
Because of the potential harm to the infant, mothers should be advised against breast-feeding while receiving Tarceva.
S obzirom na potencijalnu opasnost za dijete, za vrijeme primjene lijeka Tarceva majke ne bi trebale dojiti.
Because of the potential risk of thrombotic complications with factor IX products, clinical surveillance for early signs of thrombotic and consumptive coagulopathy should be initiated with appropriate biological testing when administering this product to patients with liver disease, to patients post-operatively, to new- born infants, or to patients at risk of thrombotic phenomena or disseminated intravascular coagulation (DIC).
Zbog mogućeg rizika od trombotičkih komplikacija uz lijekove s faktorom IX, potrebno je započeti klinički nadzor zbog mogućeg razvoja ranih znakova trombotičke i potrošne koagulopatije uz odgovarajuće biološko testiranje kad se ovaj lijek primjenjuje u bolesnika s bolešću jetre, bolesnika nakon kirurškog zahvata, novorođenčadi ili u bolesnika u kojih postoji rizik od trombotičkih pojava ili diseminirane intravaskularne koagulacije (DIK).
Because of the potential risk of thrombotic complications, clinical surveillance for early signs of thrombotic and consumptive coagulopathy should be initiated with appropriate biological testing when administering this product to patients with liver disease, to patients post-operatively, to new-born infants, or to patients at risk of thrombotic phenomena or DIC.
Zbog potencijalnog rizika trombotskih komplikacija potrebno je odgovarajućim biološkim testovima provesti kliničko praćenje ranih znakova trombotske i potrošne koagulopatije u slučajevima primjene ovog lijeka u pacijenata s jetrenom bolešću, pacijentima nakon operacije, novorođenčadi ili pacijentima s rizikom trombotskih pojava ili DIK-a.
Because of the rarity of data on treatment with hydroxycarbamide in children less than 2 years of age, dose regimens have not been established and thus, in this population, the treatment with hydroxycarbamide is not recommended.
Zbog malobrojnih podataka o terapiji hidroksikarbamidom u djece mlađe od 2 godine, nisu utvrđeni režimi doziranja te se stoga za ovu populaciju liječenje hidroksikarbamidom ne preporučuje.
Because of the risk of allergic reactions with factor IX concentrates, the initial administrations of factor IX should, according to the treating physician’s judgement, be performed under medical observation where proper medical care for allergic reactions could be provided.
Uslijed rizika pojave alergijskih reakcija na koncentrate faktora IX, početne primjene faktora IX potrebno je, prema prosudbi liječnika koji provodi liječenje, provoditi pod medicinskim nadzorom gdje je moguće pružiti odgovarajuću medicinsku skrb za alergijske reakcije.
Because of the risk of allergic reactions with factor IX concentrates, the initial administrations of factor IX should, according to the treating physician’s judgement, be performed under medical observation where proper medical care for allergic reactions could be provided.
Zbog rizika od alergijskih reakcija kod primjene koncentrata faktora IX, početne primjene faktora IX treba, sukladno procjeni nadležnog liječnika, provoditi pod medicinskim nadzorom na mjestu gdje se može osigurati odgovarajuća medicinska skrb za alergijske reakcije.
Because of the risk of allergic reactions with factor IX concentrates, the initial administrations of factor IX should, according to the treating physician’s judgement, be performed under medical observation where proper medical care for allergic reactions could be provided.
Zbog rizika od alergijskih reakcija s koncentratima faktora IX, početnu primjenu faktora IX potrebno je, sukladno procjeni nadležnog liječnika, provoditi pod liječničkim nadzorom, na mjestu gdje bi mogla biti pružena odgovarajuća medicinska skrb u slučaju alergijskih reakcija.
Because of the risk of allergic reactions with factor IX products, the initial administration of factor IX should, according to the treating physician’s judgement, be performed under medical observation where proper medical care for allergic reactions could be provided.
Zbog rizika od alergijskih reakcija kod primjene lijekova koji sadrže faktor IX, prve primjene faktora IX, sukladno procjeni nadležnog liječnika, trebaju se odvijati pod liječničkim nadzorom u uvjetima u kojima se može pružiti odgovarajuća medicinska skrb u slučaju alergijskih reakcija.
Because of the risk of allergic reactions with factor IX products, the initial administrations of factor IX should, according to the treating physician’s judgement, be performed under medical observation where proper medical care for allergic reactions could be provided.
Zbog rizika od alergijskih reakcija na lijekove s faktorom IX, početne primjene faktora IX treba, sukladno prosudbi nadležnog liječnika, provesti pod medicinskim nadzorom, gdje se može pružiti odgovarajuće medicinsko liječenje alergijskih reakcija.
Because of the risk of allergic reactions with factor IX, your initial administration of IDELVION should be performed under medical observation where proper medical care for allergic reactions can be provided.
Zbog rizika od alergijskih reakcija kod liječenja faktorom IX, početne doze lijeka IDELVION moraju se primijeniti pod liječničkim nadzorom u uvjetima u kojima se može pružiti odgovarajuća medicinska skrb u slučaju alergijskih reakcija.
Because of the risk of allergic reactions with factor IX, your initial administrations of BeneFIX should be performed under medical observation where proper medical care for allergic reactions can be provided.
Zbog rizika od alergijskih reakcija na faktor IX, prvih nekoliko primjena BeneFIX-a trebalo bi provesti pod medicinskim nadzorom na mjestu gdje se može pružiti odgovarajuća medicinska skrb u slučaju alergijske reakcije.
Because of the risk of developing OHSS, patients should be monitored for at least two weeks after hCG administration.
Zbog rizika razvoja OHSS-a, bolesnice treba pratiti najmanje dva tjedna nakon primjene hCG-a.
Because of the risk of infusion reactions, the patient is to be given preventive treatment consisting of an anti-inflammatory medicine, an antihistamine and paracetamol before every infusion.
Zbog postojanja rizika od reakcija na infuziju, bolesniku je prije svake infuzije potrebno dati preventivnu terapiju koja se sastoji od protuupalnog lijeka, antihistamina i paracetamola.
Because of the risk of liver problems, the doctor will measure the levels of liver enzymes before treatment, and every month during treatment with Tracleer.
Budući da je prisutan rizik od problema s jetrom, liječnik mjeri razine jetrenih enzima prije terapije, te svakog mjeseca tijekom liječenja lijekom Tracleer.
Because of the risk of potentially fatal, acute liver injury, Tasmar should not be considered as a first- line adjunct therapy to levodopa/benserazide or levodopa/carbidopa (see sections 4.4 and 4.8).
Zbog rizika od potencijalno smrtonosnog, akutnog oštećenja jetre, Tasmar se ne smije razmatrati kao prva linija adjuvantne terapije levodopi/benzerazidu ili levodopi/karbidopi (vidjeti dijelove 4.4 i 4.8).
Because of the risk of transmission of aspergillosis to people, personal protective equipment consisting of latex gloves and a mask should therefore be worn when handling infected birds or when cleaning the syringe.
Budući da postoji rizik od prijenosa aspergiloze na ljude, treba nositi osobnu zaštitnu opremu koja se sastoji od lateks rukavica i maske prilikom rukovanja zaraženim pticama ili prilikom čišćenja šprice.
Because of the risk of transmission of aspergillosis to people, protective personal equipment consisting of latex gloves and a mask should therefore be worn when handling infected birds or when cleaning the syringe.
Budući da postoji rizik od prijenosa aspergiloze na ljude, treba nositi osobnu zaštitnu opremu koja se sastoji od lateks rukavica i maske prilikom rukovanja zaraženim pticama ili prilikom čišćenja šprice.
Because of the study sample size and duration, the effects of Soliris on thrombotic events could not be determined.
Zbog veličine uzorka i trajanja ispitivanja, učinci lijeka Soliris na trombotičke incidente nisu se mogli utvrditi.
Because of these possible irritant effects and a potential for worsening of the underlying disease, caution should be used when Bondronat is given to patients with active upper gastrointestinal problems (e.g. known Barrett’s oesophagus, dysphagia, other oesophageal diseases, gastritis, duodenitis or ulcers).
Zbog pojave ovih mogućih iritacija i mogućnosti pogoršanja osnovne bolesti, potreban je oprez kad se Bondronat propisuje bolesnicima s problemima gornjeg dijela gastrointestinalnog sustava (na primjer Barrettov jednjak, disfagija, druge bolesti jednjaka, gastritis, upala dvanaesnika ili vrijedovi).
Because of these possible irritant effects and a potential for worsening of the underlying disease, caution should be used when Iasibon is given to patients with active upper gastrointestinal problems (e.g. known Barrett’s oesophagus, dysphagia, other oesophageal diseases, gastritis, duodenitis or ulcers).
Zbog pojave ovih mogućih iritacija i mogućnosti pogoršanja osnovne bolesti, potreban je oprez kad se Iasibon propisuje bolesnicima s problemima gornjeg dijela gastrointestinalnog sustava (na primjer Barrettov jednjak, disfagija, druge bolesti jednjaka, gastritis, upala dvanaesnika ili vrijedovi).
Because of these possible irritant effects and a potential for worsening of the underlying disease, caution should be used when Ibandronic acid Sandoz is given to patients with active upper gastrointestinal problems (e.g. known Barrett’s oesophagus, dysphagia, other oesophageal diseases, gastritis, duodenitis or ulcers).
Zbog pojave ovih mogućih iritacija i mogućnosti pogoršanja osnovne bolesti, potreban je oprez kad se Ibandronatna kiselina Sandoz propisuje bolesnicima s problemima gornjeg dijela gastrointestinalnog sustava (na primjer Barrettov jednjak, disfagija, druge bolesti jednjaka, gastritis, upala dvanaesnika ili vrijedovi).
Because of these possible irritant effects and a potential for worsening of the underlying disease, caution should be used when Ibandronic Acid Teva is given to patients with active upper gastrointestinal problems (e.g. known Barrett’s oesophagus, dysphagia, other oesophageal diseases, gastritis, duodenitis or ulcers).
Zbog pojave ovih mogućih iritacija i mogućnosti pogoršanja osnovne bolesti, potreban je oprez kad se Ibandronatna kiselina Teva propisuje bolesnicima s problemima gornjeg dijela gastrointestinalnog trakta (na primjer Barrettov jednjak, disfagija, druge bolesti jednjaka, gastritis, upala dvanaesnika ili vrijedovi).
Because of this T790M mutation, medicines that block EGFR may no longer work.
Zbog ove T790M mutacije, moguće je da lijekovi koji blokiraju EGFR više ne djeluju.
Because of this, administration of pure VWF (VWF product with a low FVIII level) restores the FVIII:C level to normal as a secondary effect after the first infusion with a slight delay.
Iz tog razloga primjena čistog VWF (lijek s VWF i niskom razinom FVIII) ponovno uspostavlja normalnu razinu FVIII:C kao sekundarni učinak nakon prve infuzije s malom odgodom.
Because of this, concomitant use of opicapone with MAO inhibitors (e.g. phenelzine, tranylcypromine and moclobemide) other than those for the treatment of Parkinson’s disease is contraindicated.
Zbog toga je kontraindicirana istodobna primjena opikapona i inhibitora MAO (npr. fenelzina, tranilcipromina i moklobemida), osim onih namijenjenih liječenju Parkinsonove bolesti.
Because Olanzapine Cipla is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as the reference medicine’s.
Budući da je Olanzapine Cipla generički lijek te je bioekvivalent referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
Because Olanzapine Glenmark is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je Olanzapine Glenmark generički lijek te je bioekvivalent referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
Because only 45 mg 13C-urea is provided overdose is not to be expected.
Predoziranje nije vjerojatno s obzirom na to da je priloženo samo 45 mg 13C-uree.
Because only 75 mg 13C-urea is provided overdose is not to be expected.
Predoziranje nije vjerojatno s obzirom na to da je priloženo samo 75 mg 13C-uree.
Because Oprymea is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as the reference medicine’s.
Budući da je Oprymea generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
Because Oprymea is a generic medicine, studies in people have been limited to tests to demonstrate that it is bioequivalent to the reference medicine, Sifrol.
Budući da je Oprymea generički lijek, ispitivanja su na bolesnicima bila ograničena na ispitivanja za utvrđivanje je li lijek bioekvivalentan referentnom lijeku Sifrol.
Because Palonosetron Accord is a generic medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je Palonosetron Accord generički lijek, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
Because Palonosetron Hospira is a generic medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je Palonosetron Hospira generički lijek, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
Because patients taking Daxas may lose weight, they are advised to weigh themselves on a regular basis.
S obzirom na to da je kod bolesnika koji uzimaju Daxas moguć gubitak tjelesne težine, savjetuje im se da se redovito važu.
Because patients with clinically relevant cardiovascular disease were excluded in these studies, patients with severe cardiovascular disease should be asked about symptoms of syncope and pre-syncope.
Budući da su bolesnici s klinički značajnom kardiovaskularnom bolesti bili isključeni iz tih ispitivanja, bolesnike s teškom kardiovaskularnom bolesti potrebno je pitati o simptomima sinkope i prensikope
Because patients with clinically relevant cardiovascular disease were excluded in these studies, patients with severe cardiovascular disease should be asked about symptoms of syncope and pre-syncope.
Budući da su bolesnici s klinički značajnom kardiovaskularnom bolesti bili isključeni iz tih ispitivanja, bolesnike s teškom kardiovaskularnom bolesti potrebno je pitati o simptomima sinkope i presikope.
Because patients with clinically relevant cardiovascular disease were excluded in these studies, patients with severe cardiovascular disease should be asked about symptoms of syncope and pre-syncope.
Budući da su bolesnici s klinički značajnom kardiovaskularnom bolesti bili isključeni iz tih ispitivanja, bolesnike s teškom kardiovaskularnom potrebno je pitati o simptomima sinkope i presinkope.
Because PecFent is a hybrid generic, the applicant presented data on the reference medicines in addition to results from its own studies.
Budući da je lijek PecFent hibridni generički lijek, podnositelj zahtjeva dostavio je podatke o referentnom lijeku uz rezultate vlastitog ispitivanja.
Because Pemetrexed Accord is a generic medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je Pemetrexed Accord generički lijek, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
Because Pemetrexed Fresenius Kabi is a generic medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je lijek Pemetrexed Fresenius Kabi generički lijek, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
Because Pemetrexed Hospira is a generic medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je Pemetrexed Hospira generički lijek, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
Because Pemetrexed Lilly is a generic medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je Pemetrexed Lilly generički lijek, smatra se da su njegovi koristi i rizici isti kao i oni referentnog lijeka.
Because Pemetrexed medac is a generic medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je Pemetrexed medac generički lijek, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
Because Pemetrexed Sandoz is a generic medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je Pemetrexed Sandoz generički lijek, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
Because Potactasol is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je Potactasol generički VMP te je bioekvivalent referentnom VMP-u, smatra se da su njegove koristi i rizici isti kao i oni referentnog VMP-a.
Because Pradaxa can increase INR, the INR will better reflect VKA’s effect only after Pradaxa has been stopped for at least 2 days.
Budući da Pradaxa može povisiti INR vrijednosti, INR će bolje odražavati učinak VKA najmanje 2 dana nakon prekida primjene Pradaxe.
Because Pramipexole Accord is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je lijek Pramipeksol Accord generički lijek i da je bioekvivalentan referentnom lijeku, smatra se da su njegovi koristi i rizici isti kao i oni referentnog lijeka.
Because Pregabalin Accord is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je lijek Pregabalin Accord generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i kod referentnog lijeka.
Because Pregabalin Accord is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Lyrica.
Budući da je Pregabalin Accord generički lijek, ispitivanja na bolesnicima bila su ograničena na ispitivanja za utvrđivanje je li lijek bioekvivalentan referentnom lijeku Lyrica.
Because Pregabalin Mylan is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je lijek Pregabalin Mylan generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i kod referentnog lijeka.
Because Pregabalin Mylan is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Lyrica.
Budući da je Pregabalin Mylan generički lijek, ispitivanja na bolesnicima bila su ograničena na ispitivanja za utvrđivanje da je lijek bioekvivalentan referentnom lijeku Lyrica.
Because Pregabalin Mylan Pharma is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je lijek Pregabalin Mylan Pharma generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i kod referentnog lijeka.
Because Pregabalin Mylan Pharma is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Lyrica.
Budući da je Pregabalin Mylan Pharma generički lijek, ispitivanja na bolesnicima bila su ograničena na ispitivanja za utvrđivanje da je lijek bioekvivalentan referentnom lijeku Lyrica.
Because Pregabalin Sandoz GmbH is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je lijek Pregabalin Sandoz generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i kod referentnog lijeka.
Because Pregabalin Sandoz is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je lijek Pregabalin Sandoz generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i kod referentnog lijeka.
Because Pregabalin Zentiva is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je lijek Pregabalin Zentiva generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i kod referentnog lijeka.
Because prostate cancer needs testosterone and other male hormones to survive and grow, by blocking these hormones, enzalutamide slows down the growth of the prostate cancer.
S obzirom na to da je karcinomu prostate potreban testosteron i drugi muški hormoni kako bi preživio i rastao, blokirajući ove hormone enzalutamid usporava rast karcinoma prostate.
Because Raloxifene Teva is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je Raloksifen Teva generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su mu koristi i rizici isti kao i kod referentnog lijeka.
Because Rasagiline Mylan is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je lijek Rasagiline Mylan generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i kod referentnog lijeka.
Because Rivastigmine 3M Health Care Ltd is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je Rivastigmine 3M Health Care Ltd generički lijek, te je bioekvivalent s referentnim lijekom, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
Because Rivastigmine Actavis is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Budući da je lijek Rivastigmin Actavis generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i kod referentnog lijeka.